Vergeer Marije R, Doornaert Patricia, Leemans C René, Buter Jan, Slotman Ben J, Langendijk Johannes A
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Radiother Oncol. 2006 Apr;79(1):39-44. doi: 10.1016/j.radonc.2006.03.008.
In the present study, prognostic values of several CT-based pre-treatment nodal and treatment-related characteristics were evaluated among patients with squamous cell head and neck cancer treated with non-surgical modalities.
Included were 79 patients with 210 pathological nodes, who underwent primary irradiation or chemoradiation. Several nodal characteristics were assessed on the planning CT scan. In addition, the 3D-dose distribution in the nodes was calculated by the planning system to allow for evaluation of underdosage in the pathological nodes and to correlate these results with control in the neck. Analysis was done on patient level (regional control) and node level (nodal control).
For regional control, total nodal volume and the use of chemotherapy in addition to radiation were significant prognostic factors. For nodal control, also the presence of central necrosis and radiological extranodal spread were of importance. In case of radiotherapy alone, a minimal dose <95% of the prescribed dose was associated with worse control. In case of combined modality treatment, the minimal radiation dose was of less importance.
Nodal volume and chemotherapy are the most important prognostic factors to control pathological nodes in the neck. Radiological central necrosis and extranodal growth, nodal volume and chemotherapy were significant prognostic factors for nodal control. Additionally, it appears that regional control in patients treated with primary radiation alone or with chemoradiation in case of a total nodal volume of more than 3.0 cm(3) results in an unacceptable high risk on regional recurrence.
在本研究中,我们评估了几种基于CT的治疗前淋巴结及治疗相关特征对接受非手术治疗的头颈部鳞状细胞癌患者的预后价值。
纳入79例患者,共210个病理淋巴结,这些患者接受了根治性放疗或同步放化疗。在计划CT扫描上评估了多个淋巴结特征。此外,计划系统计算了淋巴结内的三维剂量分布,以评估病理淋巴结的剂量不足情况,并将这些结果与颈部控制情况相关联。分析在患者层面(区域控制)和淋巴结层面(淋巴结控制)进行。
对于区域控制,总淋巴结体积以及放疗联合化疗是显著的预后因素。对于淋巴结控制,中央坏死的存在和放射学上的结外扩散也很重要。单纯放疗时,最小剂量<规定剂量的95%与较差的控制相关。在联合治疗的情况下,最小放射剂量的重要性较低。
淋巴结体积和化疗是控制颈部病理淋巴结的最重要预后因素。放射学上的中央坏死和结外生长、淋巴结体积和化疗是淋巴结控制的显著预后因素。此外,似乎对于总淋巴结体积超过3.0 cm³的患者,单纯接受根治性放疗或同步放化疗时,区域复发风险高得令人无法接受。